title: In response to the letter from Braden.
authors.affiliation: Professor of Pediatrics, Tufts University School of Medicine.
authors.forename: H Cody
authors.initials: HC
authors.lastname: Meissner
authors.affiliation: E-mail: cmeissner@tuftsmedicalcenter.org.
authors.forename: Sandra
authors.initials: S
authors.lastname: Hennessy
authors.affiliation: E-mail: cmeissner@tuftsmedicalcenter.org.
authors.forename: Emily
authors.initials: E
authors.lastname: Rowe
authors.affiliation: E-mail: cmeissner@tuftsmedicalcenter.org.
authors.forename: Michael T
authors.initials: MT
authors.lastname: Brady
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D006801:Humans; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents